問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
E-DA Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2025-11-01 - 2033-12-31
Condition/Disease
Locally advanced unresectable or metastatic HER2-overexpressing non-squamous non-small cell lung cancer
Test Drug
Trastuzumab Deruxtecan(AZD4552 DS-8201A)
Participate Sites9Sites
Recruiting9Sites
2019-12-01 - 2030-05-31
Participate Sites17Sites
Not yet recruiting4Sites
Recruiting13Sites
2021-12-01 - 2027-12-31
Participate Sites4Sites
Recruiting4Sites
2025-08-01 - 2031-12-31
Participate Sites7Sites
Recruiting7Sites
2024-01-01 - 2040-12-31
2023-04-17 - 2026-12-31
2024-03-01 - 2030-03-31
Participate Sites6Sites
Recruiting6Sites
2021-11-01 - 2026-06-30
Terminated2Sites
2024-05-01 - 2030-08-31
Participate Sites5Sites
Recruiting5Sites
2019-11-01 - 2024-05-13
Participate Sites13Sites
全部
